Daniel L. Obrzut
FDA Investigator
- Daniel L. Obrzut first started conducting FDA inspections in 2018, with the last inspection in 2024. Over that time, Daniel L. Obrzut has conducted 5 inspections at 5 companies across 5 sites.
Get Daniel Obrzut's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 NerPharMa S.r.l., Nerviano | 2024
Out of stock
FDA 483 Lilly del Caribe, Inc., Carolina | 2024
Out of stock
FDA 483 Cenexi Laboratories Thissen SA, Braine-l'Alleud | 2020
Out of stock
Co-Investigators (10)
- Jeffrey P. Raimondi, FDA Investigator
- Ruo H. Xu, FDA Investigator
- Marian E. Ramirez, FDA Investigator
- Jose E. Melendez, FDA Investigator
- Yifan Wang, FDA Investigator
- Andrew J. Barrowcliff, FDA Investigator
- Nina Ni, FDA Investigator
- Sarah E. Rhoades, FDA Investigator
- Emilie Kahn, FDA Investigator
- Lata C. Mathew, FDA Investigator